Abraxane - supply shortage

Resolved

paclitaxel

Shortage information

The shortage affecting Abraxane has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

• Medicines affected:
  Abraxane
• Supply shortage status:
  Resolved
• International non-proprietary name (INN) or common name:
  paclitaxel
• Therapeutic area (MESH):
  • Breast Neoplasms
  • Pancreatic Neoplasms
  • Carcinoma, Non-Small-Cell Lung
• Pharmaceutical forms affected:
  Powder for dispersion for injection
• Strengths affected:
  5 mg/ml
• Availability of alternatives:
  Yes

Key dates

• First published:
  11/05/2023
• Last updated:
  18/12/2023